|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||42.60 - 43.44|
|52 Week Range||18.25 - 45.55|
|PE Ratio (TTM)||-21,550.00|
|Earnings Date||Oct 24, 2017 - Oct 30, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||42.83|
Quidel Corporation (QDEL) was a big mover last session, as the company saw its shares rise more than 6% on the day amid huge volumes.
Investors appear pleased with a recent revision to a deal with another point-of-care diagnostic developer.
Quidel Corporation , a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced a revised definitive agreement with Alere Inc.